Literature DB >> 4283645

Capacity of the terminal vascular bed during normal growth, in cardiomegaly, and in cardiac atrophy.

K Rakusan, W du Mesnil de Rochemont, W Braasch, H Tschopp, R J Bing.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4283645     DOI: 10.1161/01.res.21.2.209

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  7 in total

1.  Effects of hypoxia on coronary microcirculation during postnatal development.

Authors:  Fumio Yamamoto; Hiroshi Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-10-08

2.  PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function.

Authors:  Filio Billia; Ludger Hauck; Filip Konecny; Vivek Rao; Jie Shen; Tak Wah Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

3.  Isoprenaline-induced changes in regional myocardial perfusion in the pathogenesis of myocardial necrosis.

Authors:  P Collins; C G Billings
Journal:  Br J Exp Pathol       Date:  1976-12

4.  Myocardial capillary density and muscle fibre size in rats born and raised at simulated high altitude.

Authors:  P Smith; D R Clark
Journal:  Br J Exp Pathol       Date:  1979-04

5.  Transmural distribution of myocardial blood flow and of coronary reserve in canine left ventricular hypertrophy.

Authors:  J Holtz; W V Restorff; P Bard; E Bassenge
Journal:  Basic Res Cardiol       Date:  1977 Mar-Jun       Impact factor: 17.165

Review 6.  Hypertension and age-related changes in the heart. Implications for drug therapy.

Authors:  S Isoyama
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

7.  Left ventricular mass and arterial compliance: relation to coronary heart disease and its risk factors in South Indian adults.

Authors:  K Kumaran; Caroline H D Fall; Christopher N Martyn; M Vijayakumar; Claudia E Stein; Rosie Shier
Journal:  Int J Cardiol       Date:  2002-04       Impact factor: 4.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.